Variant report
Variant | esv3446868 |
---|---|
Chromosome Location | chr5:151459109-151463407 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547876120 | chr5:151462614-151462615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565894700 | chr5:151462624-151462625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533378918 | chr5:151462625-151462626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182945974 | chr5:151462682-151462683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74989168 | chr5:151462732-151462733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79240275 | chr5:151462750-151462751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543299564 | chr5:151462839-151462840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141428559 | chr5:151462879-151462880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540352887 | chr5:151462898-151462899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187800302 | chr5:151462902-151462903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534371021 | chr5:151462906-151462907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553039038 | chr5:151462950-151462951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146185518 | chr5:151462958-151462959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191820791 | chr5:151462966-151462967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556823481 | chr5:151463034-151463035 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs693104 | chr5:151463117-151463118 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs542412333 | chr5:151463129-151463130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560705877 | chr5:151463143-151463144 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572486510 | chr5:151463163-151463164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139148811 | chr5:151463179-151463180 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77064734 | chr5:151463240-151463241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182818538 | chr5:151463272-151463273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187509208 | chr5:151463285-151463286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533152940 | chr5:151463298-151463299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs58154828 | chr5:151463392-151463393 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Parkinson disease | 21829596 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:151462600-151464400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:151462800-151463000 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr5:151463000-151463800 | Weak transcription | Fetal Muscle Leg | muscle |